January 2012
Paget’s disease is a chronic disorder that can result in enlarged and misshapen bones. The excessive breakdown and formation of bone tissue causes affected bone to weaken—resulting in bone pain, misshapen bones, fractures, and arthritis in the joints near the affected bones. Paget’s disease typically is localized, affecting just one or a few bones, as opposed to osteoporosis, for example, which affects all the bones in the body.
Scientists do not know for sure what causes Paget’s disease. In some cases, the disease runs in families, and so far two genes have been identified that predispose affected people to develop Paget’s disease. In most cases, however, scientists suspect that environmental factors play a role. For example, scientists are studying the possibility that a slow-acting virus may cause Paget’s disease.
The disease is more common in older people and those of northern European heritage. Research suggests that a close relative of someone with Paget’s disease is seven times more likely to develop the disease than someone without an affected relative.
Many patients do not know they have Paget’s disease because they have no symptoms. Sometimes the symptoms may be confused with those of arthritis or other disorders. In other cases, the diagnosis is made only after the patient has developed complications.
Symptoms can include:
Any bone or bones can be affected, but Paget’s disease occurs most frequently in the spine, pelvis, legs, or skull. Generally, symptoms progress slowly, and the disease does not spread to normal bones.
Paget’s disease is almost always diagnosed using x rays but may be discovered initially by either of the following tests:
If a blood test or bone scan suggests Paget’s disease, the affected bone(s) should be x rayed to confirm the diagnosis.
Early diagnosis and treatment are important to minimize complications. Siblings and children of people with Paget’s disease may wish to have an alkaline phosphatase blood test every 2 or 3 years starting around the age of 40. If the alkaline phosphatase level is higher than normal, a bone scan may be used to identify which bone or bones are affected and an x ray of these bones is used to verify the diagnosis of Paget’s disease.
The outlook for people diagnosed with Paget’s disease is generally good, particularly if treatment is given before major changes have occurred in the affected bones. Treatment can reduce symptoms but is not a cure. Osteogenic sarcoma, a form of bone cancer, is an extremely rare complication that occurs in less than 1 percent of all patients with Paget’s disease.
Paget’s disease may lead to other medical conditions, including:
Paget’s disease is not associated with osteoporosis. Although Paget’s disease and osteoporosis can occur in the same patient, they are completely different disorders. Despite their marked differences, several medications for Paget’s disease also are used to treat osteoporosis.
The following types of medical specialists are generally knowledgeable about treating Paget’s disease:
Drug therapy: The Food and Drug Administration has approved several medications to treat Paget’s disease. The medications work by controlling the excessive breakdown and formation of bone that occurs in the disease. The goal of treatment is to relieve bone pain and prevent progression of the disease. People with Paget’s disease should talk to their doctors about which medication is right for them. It is also important to get adequate calcium and vitamin D through diet and supplements as prescribed by your doctor, except for patients who have had kidney stones.
Bisphosphonates are a class of drugs used to treat a variety of bone diseases. Several bisphosphonates are currently available to treat Paget’s disease. Calcitonin is a naturally occurring hormone made by the thyroid gland. The medication may be appropriate for certain patients but is less effective than bisphosphonates and seldom used.
Surgery: Medical therapy before surgery helps decrease bleeding and other complications. Patients who are having surgery should discuss pretreatment with their doctor. Surgery may be advised for three major complications of Paget’s disease:
Complications resulting from enlargement of the skull or spine may injure the nervous system. However, most neurological symptoms, even those that are moderately severe, can be treated with medication and do not require neurosurgery.
Diet and exercise: There is no special diet to prevent or help treat Paget’s disease. However, according to the Institute of Medicine of the National Academy of Sciences, women age 50 and older and men age 70 and older should get 1,200 mg of calcium and at least 600 IU (International Units) of vitamin D every day to maintain a healthy skeleton. People age 70 and older need to increase their vitamin D intake to 800 IU. People with a history of kidney stones should discuss calcium and vitamin D intake with their doctor.
Exercise is important because it helps preserve skeletal health, prevent weight gain, and maintain joint mobility. Patients should discuss any new exercise program with their doctor before beginning, to avoid any undue stress on affected bones.
For more information about Paget’s disease, contact:
Website: http://www.paget.org
The National Institutes of Health Osteoporosis and Related Bone Diseases ~
National Resource Center acknowledges the assistance of the National
Osteoporosis Foundation in the preparation of this publication.
This publication contains information about medications used to treat the health condition discussed here. When this publication was produced, we included the most up-to-date (accurate) information available. Occasionally, new information on medication is released.
For updates and for any questions about any medications you are taking, please contact:
Website: http://www.fda.gov
Toll free: 888–INFO–FDA (888–463–6332)
For updates and questions about statistics, please contact:
Website: http://www.cdc.gov/nchs
Toll free: 800–232–4636
2 AMS Circle
Bethesda, MD 20892-3676
Phone: 202-223-0344
Toll Free: 800-624-BONE (2663)
TTY: 202-466-4315
Fax: 202-293-2356
Email: NIHBoneInfo@mail.nih.gov
Website: http://www.bones.nih.gov
The NIH Osteoporosis and Related Bone Diseases ~ National Resource Center provides patients, health professionals, and the public with an important link to resources and information on metabolic bone diseases. The mission of NIH ORBD~NRC is to expand awareness and enhance knowledge and understanding of the prevention, early detection, and treatment of these diseases as well as strategies for coping with them.
The NIH Osteoporosis and Related Bone Diseases ~ National Resource Center is supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases with contributions from:
The National Institutes of Health (NIH) is a component of the U.S. Department of Health and Human Services (DHHS).
Most of our bone publications are available online only. Some are available in print. Would you like to order publications on bone disorders to be mailed to you? Visit our online order form.